Correlation Between Kering SA and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kering SA and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kering SA and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kering SA and BioNTech SE, you can compare the effects of market volatilities on Kering SA and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kering SA with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kering SA and BioNTech.

Diversification Opportunities for Kering SA and BioNTech

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Kering and BioNTech is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Kering SA and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Kering SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kering SA are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Kering SA i.e., Kering SA and BioNTech go up and down completely randomly.

Pair Corralation between Kering SA and BioNTech

Assuming the 90 days trading horizon Kering SA is expected to generate 1.29 times more return on investment than BioNTech. However, Kering SA is 1.29 times more volatile than BioNTech SE. It trades about -0.05 of its potential returns per unit of risk. BioNTech SE is currently generating about -0.15 per unit of risk. If you would invest  23,541  in Kering SA on December 24, 2024 and sell it today you would lose (2,446) from holding Kering SA or give up 10.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kering SA  vs.  BioNTech SE

 Performance 
       Timeline  
Kering SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Kering SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
BioNTech SE 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Kering SA and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kering SA and BioNTech

The main advantage of trading using opposite Kering SA and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kering SA position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind Kering SA and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges